脑部放疗，上午比下午敏感许多！
[* c/ n1 _+ p' C/ l3 `
3 L5 _( q+ L& g# p; F. y
9 ~/ K0 Y9 F, ~Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
( u$ l7 M* ^ O* w: kGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
. k9 u) \) K6 ~6 u3 [# TRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
5 E8 y w( A$ T, n/ Y- p- BSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
: I9 l; Y. I5 ~3 S6 _: a
6 I8 {. _0 l1 g+ m% ?$ WAbstract; p# K" n% t2 l- U$ h$ Z8 g7 H
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.% a& U3 @- R% }# w( S( }( _
5 J& P0 Y* G7 T& I
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
* b, |5 h6 j; m/ V1 X7 l" f
c8 d- i1 m! b2 w& \2 Y0 N2 u8 _+ vRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).7 G% i* Q: s; Z% r4 g: ]9 X0 o- ]
+ y9 T3 e9 v$ g, b% O# A/ p2 D& _
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series. v2 g( M# n6 `, @" t6 ]$ n9 q
4 p5 x3 X% @# m- S! S8 ?1 ^- R- O
|
11011102001537 )
# k Z# |! \% G- W+ x; ~
显身卡
